• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    6.79 Up 0.32(4.95%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.47
    Open:6.49
    Bid:6.29 x 100
    Ask:N/A
    1y Target Est:13.83
    Beta:N/A
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:6.40 - 6.85
    52wk Range:3.80 - 8.16
    Volume:127,789
    Avg Vol (3m):296,347
    Market Cap:267.23M
    P/E (ttm):N/A
    EPS (ttm):-2.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNUp 4.95%267.23M
    CYTKDown 0.80%240.82M
    NVSDown 0.90%251.35B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.53
    Quarterly EPS Est (Jun-15) :-0.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback